Immunocore Holdings (IMCR) Inventory (2022 - 2026)

Immunocore Holdings (IMCR) has reported Inventory for 5 consecutive years, with $8.3 million the latest figure, recorded in Q1 2026.

• Quarterly Inventory rose 21.3% year-over-year to $8.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.3 million (up 21.3% YoY) and the FY2025 annual result came in at $6.7 million, up 23.8% from the prior year.
• Inventory climbed to $8.3 million in Q1 2026 per IMCR's latest filing, from $6.7 million in the prior quarter.
• Over the last five years, Inventory for IMCR reached as high as $8.3 million in Q1 2026 and fell as low as $1.0 million in Q3 2022.
• A 5-year average of $4.6 million and a median of $4.5 million in 2024 frame the typical range for Inventory.
• Annual changes were most pronounced in 2023 — Inventory surged 306.94% — and 2024, when it grew 21.0%.
• Year by year, Inventory stood at $1.1 million in 2022, then jumped by 306.94% to $4.5 million in 2023, then grew by 21.0% to $5.4 million in 2024, then advanced by 23.8% to $6.7 million in 2025, then rose by 22.41% to $8.3 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $8.3 million, $6.7 million, and $5.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.